102 related articles for article (PubMed ID: 22907344)
1. Computer-assisted modeling of antibody variable domains.
Ramos OH
Methods Mol Biol; 2012; 907():39-55. PubMed ID: 22907344
[TBL] [Abstract][Full Text] [Related]
2. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
[TBL] [Abstract][Full Text] [Related]
3. Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool.
Honegger A; Plückthun A
J Mol Biol; 2001 Jun; 309(3):657-70. PubMed ID: 11397087
[TBL] [Abstract][Full Text] [Related]
4. PIGS: automatic prediction of antibody structures.
Marcatili P; Rosi A; Tramontano A
Bioinformatics; 2008 Sep; 24(17):1953-4. PubMed ID: 18641403
[TBL] [Abstract][Full Text] [Related]
5. High-resolution modeling of antibody structures by a combination of bioinformatics, expert knowledge, and molecular simulations.
Shirai H; Ikeda K; Yamashita K; Tsuchiya Y; Sarmiento J; Liang S; Morokata T; Mizuguchi K; Higo J; Standley DM; Nakamura H
Proteins; 2014 Aug; 82(8):1624-35. PubMed ID: 24756852
[TBL] [Abstract][Full Text] [Related]
6. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
Narayanan A; Sellers BD; Jacobson MP
J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
[TBL] [Abstract][Full Text] [Related]
7. A germline knowledge based computational approach for determining antibody complementarity determining regions.
Zhao S; Lu J
Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452
[TBL] [Abstract][Full Text] [Related]
8. Structural classification of CDR-H3 revisited: a lesson in antibody modeling.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2008 Nov; 73(3):608-20. PubMed ID: 18473362
[TBL] [Abstract][Full Text] [Related]
9. Antibody modeling assessment.
Almagro JC; Beavers MP; Hernandez-Guzman F; Maier J; Shaulsky J; Butenhof K; Labute P; Thorsteinson N; Kelly K; Teplyakov A; Luo J; Sweet R; Gilliland GL
Proteins; 2011 Nov; 79(11):3050-66. PubMed ID: 21935986
[TBL] [Abstract][Full Text] [Related]
10. Predicting antibody complementarity determining region structures without classification.
Choi Y; Deane CM
Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
[TBL] [Abstract][Full Text] [Related]
11. Methods for the homology modeling of antibody variable regions.
Sircar A
Methods Mol Biol; 2012; 857():301-11. PubMed ID: 22323227
[TBL] [Abstract][Full Text] [Related]
12. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
[TBL] [Abstract][Full Text] [Related]
13. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
14. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
[TBL] [Abstract][Full Text] [Related]
15. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
[TBL] [Abstract][Full Text] [Related]
16. RosettaAntibody: antibody variable region homology modeling server.
Sircar A; Kim ET; Gray JJ
Nucleic Acids Res; 2009 Jul; 37(Web Server issue):W474-9. PubMed ID: 19458157
[TBL] [Abstract][Full Text] [Related]
17. Automated antibody structure prediction using Accelrys tools: results and best practices.
Fasnacht M; Butenhof K; Goupil-Lamy A; Hernandez-Guzman F; Huang H; Yan L
Proteins; 2014 Aug; 82(8):1583-98. PubMed ID: 24833271
[TBL] [Abstract][Full Text] [Related]
18. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
[TBL] [Abstract][Full Text] [Related]
19. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
[TBL] [Abstract][Full Text] [Related]
20. Collagen type II is recognized by a pathogenic antibody through germline encoded structures.
Böiers U; Lanig H; Sehnert B; Holmdahl R; Burkhardt H
Eur J Immunol; 2008 Oct; 38(10):2784-95. PubMed ID: 18825755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
